Company / Cash per Share
Atea Pharmaceuticals, Inc. Cash per Share History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$2.27
FY2022
5-year range
$2.15 / $10.31
FY2020-FY2022
Trend
-78.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $2.15 to $2.27 over the past 2 years.
Based on SEC 10-K filings.
2.27 in FY2022.
Improved from $2.15 to $2.27 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, cash per share decreased 78.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 10.30 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $2.27 | -78.0% |
| FY2021 | $10.31 | +380.4% |
| FY2020 | $2.15 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026